IGC Pharma, Inc. (IGC)

[NetworkNewsWire]

IGC CEO Featured in Audio Interview with NetworkNewsWire

Multifaceted financial news and publishing company NetworkNewsWire this morning announced the online availability of a new audio interview with India Globalization Capital, Inc. (NYSE MKT: IGC) CEO Ram Mukunda. In the interview, Mukunda discusses IGC’s operations and targeted market, as well as leading formulations currently in the company’s development pipeline. “This is a very exciting time for us, an exciting opportunity,” Mukunda noted in the interview. “We believe that we have first-mover advantage in combination therapy, as very few companies are actually working on cannabis-based pharmaceuticals and within that space we believe that we are the only ones working on combination therapy.” In addition to covering IGC’s development programs, Mukunda uses the interview to speak about his own professional background and those of IGC’s management team, in addition to discussing the company’s forward plans for 2017. To listen to the full interview, visit http://nnw.fm/igc-interview-march-2017.

To view the full press release, visit http://nnw.fm/g1Yfp

About IGC

India Globalization Capital is engaged in the development of cannabis-based therapies to treat pain, PTSD, seizures, cachexia, chronic and terminal neurological and oncological diagnoses, and other life altering conditions. In support of this mission, IGC has assembled a portfolio of patent filings for its phytocannabinoid-based treatments. The company is based in Bethesda, Maryland. For more information, visit www.igcinc.us.